HMTLF yields 0.83% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, HMTLF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HMTLF + MRK for your $10,000?
Hitachi Metals, Ltd. manufacture and sell specialty steel products, functional components and equipment, magnetic materials and applications/power electronics materials, wires and cables, and related products in Japan, North America, Asia, Europe, and internationally. The company's Specialty Steel Products segment offers molds and tool steels, rolls for steel mills, injection molding machine parts, structural ceramic products, and steel-frame joints for construction; automobile-related materials, razor and blade materials, precision cast components, and aircraft- and energy-related materials; and display-related materials, semiconductor and other package materials, and battery-related materials. Its Functional Components and Equipment segment provides HNM ductile cast iron products, cast iron products for transportation equipment, heat-resistant exhaust casting components, and Aluminum components; and piping and infrastructure components. The company's Magnetic Materials and Applications/Power Electronics Materials segment offers rare-earth magnets, ferrite magnets, and other magnets and applied products; and amorphous metals, nanocrystalline magnetic materials, soft ferrite, and applied products, as well as ceramic components. Its Wires, Cables, and Related Products segment provides industrial cables, electronic wires, electric equipment materials, cable assemblies, and industrial rubber products; and automotive electronic components and brake hoses. The company was founded in 1910 and is headquartered in Tokyo, Japan. Hitachi Metals, Ltd. is a subsidiary of Hitachi, Ltd.
Full HMTLF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.